Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients
Schmitt, E.W.; Nijssen, J.
Die Medizinische Welt 29(29-30): 1170-1174
1978
ISSN/ISBN: 0025-8512 PMID: 149889 Document Number: 133645
Document emailed within 1 workday
Related Documents
Leubner, H. 1973: Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563) Wiener Medizinische Wochenschrift 123(17): 277-282Voss, D.; Fuchs, G.; Schneider, D.; Schneider, J. 1972: Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis Arzneimittel-Forschung 22(Suppl 12a): 2219
Rodríguez-Miñón, J.L.; Herrera Pombo, J.L.; Marrón, J.A. 1971: Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent) Revista Clinica Espanola 123(5): 439-442
Behpour, A. 1980: Diabetes in adults and old age. Treatment with an oral antidiabetic agent Zfa. Zeitschrift für Allgemeinmedizin 56(22): 1412-1414
Sieberová, R. 1971: Clinical experiences with administration of oral antidiabetic agent Buformin Casopis Lekaru Ceskych 110(18): 420-421
Uglesic, A.; Ljahnicky, N. 1975: Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases Medizinische Monatsschrift 29(9): 408-411
D'Onofrio, F.; Pempinello, R.; Romis, L. 1972: Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide Arzneimittel-Forschung 22(11): 1879-1881
Haslbeck, M. 1979: New aspects of therapy with oral antidiabetic agents Wiener Medizinische Wochenschrift 199(24): 689-695
Sollich, V.; Klöditz, E.; Schuster, R.; Handrick, W.; Brömme, S.; Rumler, W.; Patsch, R.; Kharari, H.; Spencker, F.B. 1993: Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study Kinderarztliche Praxis 61(6): 211-214
Krüsmann, W.; Slanina, J.; Boser, F.; Löhr, G.W. 1988: Changes in concentrations of IgM, IgA and IgM immune globulins after megavolt therapy with the large-field technic in patients with Hodgkin's disease Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 164(6): 323-329
Beringer, A. 1974: Oral antidiabetic therapy with delayed-action glibenclamide and phenformin in fixed combination Minerva Medica 65(60): 3127-3139
Weinstein, A.L.; Mahoney, M.C.; Nasca, P.C.; Leske, M.C.; Varma, A.O. 1991: Breast cancer risk and oral contraceptive use: results from a large case-control study Epidemiology 2(5): 353-358
Schiefer, U.; Gisolf, A.C.; Kirsch, J.; Selbmann, H.K.; Zrenner, E. 1996: Noise field screening. Results of a television field study for detection of visual field defects Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 93(5): 604-616
Stańczyk, J.; Otto-Buczkowska, E.; Jarosz-Chobot, P.ła.; Nowowiejska, B. 2008: Used of oral antidiabetic agents in pediatric patients - own observations Endokrynologia Polska 59(5): 434-443
Kuritzky, L. 2006: Addition of basal insulin to oral antidiabetic agents: a goal-directed approach to type 2 diabetes therapy Medgenmed: Medscape General Medicine 8(4): 34
Pemler, K.; Penth, B.; Adams, H.J. 1979: Pentoxifylline medication within the scope of leg-ulcer therapy. Results of a field study using Trental 400 Fortschritte der Medizin 97(21): 1019-1022
Bergis, K. 1979: Results of a field study with Moducrin in 12596 hypertensive patients Die Medizinische Welt 30(46): 1733-1737
Maeshiba, Y.; Kiyota, Y.; Yamashita, K.; Yoshimura, Y.; Motohashi, M.; Tanayama, S. 1997: Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys Arzneimittel-Forschung 47(1): 29-35
Grujić, M.; Rizvanbegović, B.; Perinović, M.; Perinović, I.D. 1976: Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds Medicinski Arhiv 30(2): 119-121
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s